---
title: "Day 3"
author: "omicsolution"
account: "omicsolution"
published_at: "2021-06-08T08:37:20+08:00"
captured_at: "2026-08-24T11:50:16.278569+08:00"
source_url: "https://mp.weixin.qq.com/s?__biz=MzI2MTI5NDAzNg==&mid=100002125&idx=3&sn=527a567164dea1ec6c35aa45c42fe7b1&chksm=6a5ddbf65d2a52e003fdf1b238fb0de25aee71efcf172a0ba4ef2474234d9f12a184b1e4699f#rd"
---

# Day 3
10:00 - 10:05 Welcome and Introduction

Chris Adams, Ph.D., Business Development Director, Global Bioinformatics, Life Science Mass Spectrometry, Bruker Daltonics, Billerica, MA, USA

10:05 - 10:20 Plasma proteomics using Proteograph with the timsTOF Pro

Daniel Hornburg, Principal Scientist, Seer Inc., 3800 Bridge Parkway, Suite 102, Redwood City, CA 94065, USA

10:20 - 10:35 Unleashing the power of dia-PASEF with the Evosep One

Nicolai Bache, Ph.D., Head of Applications, Evosep Biosystems, Buchwaldsgade 35, 3., 5000 Odense, Denmark

10:35 - 10:50 Streamlined & automated sample processing for in-depth proteomic analyses

Garwin Pichler, Ph.D., CEO, PreOmics GmbH, ‍Am Klopferspitz 19, 82152 Planegg/Martinsried, Germany

10:50 - 11:05 High-throughput clinical proteomics and applications to COVID-19

Philipp E. Geyer, Ph.D., CSO, OmicEra Diagnostics GmbH, Behringstr. 6, 82152 Planegg, Germany

11:05 - 11:20 4D Proteomics Using Biognosys Software

Fabia Simona, Ph.D., Scientific Business Development Manager, Biognosys AG, Wagistrasse 21, 8952 Schlieren, Switzerland

11:20 - 11:35 More stable, higher depth, and More trace amount: analysis of protein post-translational modifications based on parallel accumulation – serial fragmentation combined with data-independent acquisition (diaPASEF) mode

Li Ziyi, Ph.D., Senior R&D Specialist, Shanghai Applied Protein Technology Co., Ltd., Shanghai, China

11:35 - 11:45 Q&A and Closing

Lucy Woods, Ph.D., Business Unit Manager Phenomics and Metabolomics, Bruker Daltonics, Billerica, MA, USA